Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26211827

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2015 Oct 3
First author
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2015 Oct 3;386(10001):1317-1319. doi: 10.1016/S0140-6736(15)61206-5.
    note
    Source null
    related pmid
    26211823
    relationship
    Comment in

Authors and identifiers

  1. name
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    type
    CollectiveName
bibliography ids
  1. nci-bib-a9c2de79a35ca1777702ed41
book metadata
content sha256
202f53a3083ada6e2ea9097d7a380684e2b1550de1d83fc81c12ff47334051b2
document type
citation
dois
  1. 10.1016/S0140-6736(15)61074-1
electronic publication date
display
2015 Jul 23
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26211827
immutable id
pubmed:26211827@202f53a3083ada6e2ea9097d7a380684e2b1550de1d83fc81c12ff47334051b2
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10001
name
Lancet (London, England)
nlm unique id
2985213R
pages
1341-1352
volume
386
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2015 Oct 3;386(10001):1317-1319. doi: 10.1016/S0140-6736(15)61206-5.
    note
    Source null
    related pmid
    26211823
    relationship
    Comment in
outcomes validated
false
pmid
26211827
provenance
batch id
4c1ece5bfc3d8e2be622
provider
NCBI PubMed ESummary
record sha256
e1bde83f0d1425b16aeae38801007ac4f77f9d00f99284214feea358e9e7d780
response sha256
85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
retrieved at
2026-09-09T23:47:12.730551+00:00
publication date
display
2015 Oct 3
precision
day
year
2015
publication types
  1. Comparative Study
  2. Journal Article
  3. Meta-Analysis
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26211827/
title
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Preserved source evidence · Not medical advice